Unlock instant, AI-driven research and patent intelligence for your innovation.
Aralkylone pipeazine derivative and its application
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
一种芳烷酮哌嗪、衍生物的技术,应用在芳烷酮哌嗪衍生物领域,能够解决胃蠕动减少等问题
Inactive Publication Date: 2002-11-27
NHWA PHARMA CORPORATION +1
View PDF0 Cites 20 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0003] One of the technical problems to be solved in the present invention is to disclose a class of aralkylone piperazine compounds with medical value, to overcome the defects of existing drugs with side effects such as addiction, respiratory depression, and gastric motility reduction, and to solve clinical problems. Meet people's analgesic needs;
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1IV-1
[0098] Example 1IV-1 N 1 -Benzyl-N 4 -Phenylmethylpiperazine hydrochloride
[0099] N-benzylpiperazine hydrochloride 3.98g (16mmol), acetophenone chloride 2.97g (19.2mmol) and anhydrous K 2 CO 3 7.73g (56mmol) was synthesized in acetone according to general method two to obtain 4.5g of white solid, yield 75%, mp 238-9°C.
[0100] Elemental analysis: C 19 H 22 N 2 O·2HCl·H 2 O (theoretical value%: C 59.31, H 6.8, N 7.27, Cl 18.4; experimental value% C 59.38, H 6.51, N 7.12, Cl 18.23)
[0104] Example 2IV-2 N 1 -P-chlorobenzyl-N 4 -(1-Benzoylethyl)piperazine hydrochloride
[0105] Take N-p-chlorobenzylpiperazine hydrochloride 5g (20mmol), anhydrous KHCO 3 (70mmol) and 3.96ml (26mmol) of 2-bromopropiophenone, reacted at reflux in 40ml of absolute ethanol for 8 hours. After treatment according to the general method, the product is 6.1g, yield 59.51%, mp260-262℃
[0106] Elemental analysis: C 20 H 23 ClN 2 O·2HCl·H 2 O (theoretical value%: C 55.37, H 6.27, N 6.46; experimental value% C55.01, H 6.01, N 6.41)
Embodiment 3IV-3
[0107] MS: m / z 342(M + ) Example 3IV-3 N 1 -P-chlorobenzyl-N 4 -Phenylmethylpiperazine hydrochloride
[0108] Take 5g (20mmol) of N-p-chlorobenzylpiperazine hydrochloride, 5.58ml (40mmol) of triethylamine and 4.08g (26mmol) of chloroacetophenone, reflux for 8 hours in 40ml of absolute ethanol, press the pass After the second treatment method, the product is 5.2g, the yield is 59.51%, mp256-258℃
[0109] Elemental analysis: C 19 H 21 ClN 2 O·2HCl·H 2 O (theoretical value%: C 55.37, H 6.27, N 6.46; experimental value% C55.01, H 6.01, N 6.41)
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
An aralkylone piperazine derivative and its application to preparing antalgic and sedative medicines are disclosed. Its advantages are high antalgic effect to control nerve, no dependency, low poisonand little nerve by-effect.
Description
Technical field [0001] The invention relates to an aralkanone piperazine derivative and its application as a novel analgesic and tranquilizer. Background technique [0002] Severe acute and chronic pain, including tumor pain and postoperative pain, plagues tens of millions of patients, and is currently a major clinical problem. Due to the addictive nature of the existing opioid analgesics, respiratory depression, reduced gastric motility and other side effects, which limit their widespread use, we are looking for a center that can maintain a strong analgesic effect, but also overcome the above-mentioned drawbacks, and be safe for clinical use. Analgesic drugs are not only the main research goal in the field of analgesia, but also an important area of innovative drug research. Summary of the invention [0003] One of the technical problems that the present invention needs to solve is to disclose a class of aralkanone piperazine compounds with medical value, so as to overcome th...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.